Canadian Pegvisomant Compassionate Study In Acromegalic Patients
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are: 1) to provide SOMAVERT for compassionate use to patients with
acromegaly or who have completed clinical trials and were responsive, and 2) to evaluate the
safety and tolerability of SOMAVERT.